Immunogenicity ELISA

Immunogenicity ELISA

As patents on many major biologics are expected to expire, it's estimated that roughly half of the large molecule therapeutics market, will be open to competition from large molecule generics, often referred to as biosimilars or follow-on biologics.

KRISHGEN is a pioneer in this market to be able to offer a wide range of assays for the potency / assay testing and for immunogenicity testing. We have experience in developing and validating new assays to International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) standards.

Check flyer of Anti AAV5 ELISA

View as Grid List

Items 1-9 of 24

Page
per page
Set Descending Direction
View as Grid List

Items 1-9 of 24

Page
per page
Set Descending Direction